Accelerant Holdings (ARX) Fair Value 2026

ARX · Insurance Brokers ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.9 /10

32 fundamental signals · 12 models active

Value Trap Risk

(—/100)

Quick Summary — As of 2026-07-13, Accelerant Holdings (ARX) trades at $13.34, approximately 76% below CirclFi’s Bayesian DCF fair value of $54.55. QOC: 6.9/10. 12/13 models active.

Key Facts

Ticker
ARX
Price
$13.34
Quality Score
6.9/10
Value Trap Risk
—/100
Models Active
12/13
Last Updated
Strength: Bayesian DCF suggests +308.9% upside with 53% confidence
Risk: Limited model coverage (12/13) may reduce confidence

Valuation Matrix

12 Intrinsic Value Models vs. Current Price ($13.34)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
$54.55 +308.9%
Earnings Power Value
Medium Conviction
$1.32 -90.1%
CUCE Ensemble
Low Conviction
$14.19 +6.4%
First Chicago
Medium Conviction
$10.65 -20.2%

Unlock the Full Matrix

Access 8 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 12 Models →

Cancel anytime · No contracts · Instant access

What Is Accelerant Holdings (ARX) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Accelerant Holdings at its current price of $13.34. The composite intrinsic value is estimated at $15.29 (+14.6% average return), with 7 models flagging overvaluation risk. Notably, RCMH-DCF sees the most upside at +312.2% (fair value: $54.99), while Markov DDM is the most conservative at -98.9% ($0.15). The spread between these extremes — +411.1% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About ARX?

12 of 13 models are currently active for ARX. Of these, 4 models suggest upside while 8 models suggest overvaluation. The Bayesian DCF estimates ARX's intrinsic value at $54.55, implying +308.9% upside from the current price. See which stocks rank higher →

How Does ARX Rank in Insurance Brokers?

Among 4 Insurance Brokers stocks, ARX ranks #4 by Quality of Company score. CirclFi's QOC score of 6.9/10 evaluates 32 fundamental signals. A score of 6.9 indicates above-average quality.

Within the Insurance Brokers space, Accelerant Holdings competes in an environment where expense ratio often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is ARX a Value Trap?

The Value Trap algorithm is not active for ARX. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

12 of 13 models are active for Accelerant Holdings. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Accelerant Holdings's fundamental quality profile registers 6.9/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +411.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ARX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across ARX's 12 active models, average confidence is 29%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Accelerant Holdings Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Insurance Brokers Stocks Should You Also Analyze?

3 related Insurance Brokers stocks with 13-model coverage

Read investment analysis: AJG · AON · AIFU

Frequently Asked Questions About Accelerant Holdings

What is Accelerant Holdings's intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Accelerant Holdings (ARX) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $54.55. The Quality of Company score is 6.9/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ARX overvalued or undervalued right now?

At $13.34, 4 of 12 active models suggest ARX may be undervalued, while 8 indicate potential overvaluation. The assessment depends on which methodology best fits Accelerant Holdings's business model in Insurance Brokers.

What does a Quality of Company score of 6.9 mean for ARX?

Accelerant Holdings's QOC of 6.9/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on ARX?

CirclFi analyzes ARX with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 12 of 13 are active for this stock. Read the full methodology →

Is ARX a value trap in 2026?

CirclFi's Value Trap algorithm does not have sufficient data for ARX at this time. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 12 mathematical frameworks give you clarity on ARX.

Unlock All 12 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access